Map competitor trials by condition, phase and sponsor
Business development and competitive-intelligence teams need to know who is running what, where and how big. Trialtide lets you answer that with filters instead of manual searches.
How pharma and biotech teams use Trialtide
- Filter by condition (or MeSH term) and phase to see the competitive set.
- Group by lead sponsor and sum enrollment and site counts.
- Filter status = recruiting and sort by primary completion date to see what reads out next.
- Check any trial you act on against its live ClinicalTrials.gov record.
General information only, not medical or regulatory advice. Registry entries are what sponsors report and can lag reality.
Industry phase 3 trials recruiting now, most sites first (build of 24 Sep 2026, registry data 23 Sep)
| NCT ID | Lead sponsor | Condition | Enrolling | Sites | Primary completion |
|---|---|---|---|---|---|
| NCT07000357 | AstraZeneca | Cardiovascular disease | 15,100 | 1,452 | 2029-10-26 |
| NCT07181109 | Alnylam Pharmaceuticals | Hypertension | 11,000 | 1,153 | 2030-09-23 |
| NCT07064473 | Boehringer Ingelheim | Type 2 diabetes | 11,800 | 1,143 | 2029-12-14 |
| NCT06677060 | AstraZeneca | Heart failure | 11,300 | 957 | 2029-12-17 |
| NCT07567001 | Novo Nordisk A/S | Obesity; heart failure | 5,610 | 838 | 2029-07-23 |
Source: Trialtide studies table, build of 24 Sep 2026 (products/trialtide/store/listing.json; HF dataset CyberMax-tools/trialtide-clinicaltrials-registry). Source: ClinicalTrials.gov (US National Library of Medicine). Not medical advice.
FAQ
Why not a commercial trial database?
Commercial databases add curated outcomes and analyst notes. If you only need the registry itself as data, Trialtide is free.
How fresh is it?
It is a snapshot; the build date is on the dataset card.
Trialtide: full guide with prices and alternatives · All use cases · Store